Banner

Almorexant hydrochloride

Almorexant hydrochloride

Almorexant hydrochloride

Catalog No.: PC0175

Size: 1 mg, 5 mg,10 mg, 50 mg, 100 mg, 200 mg, 500 mg


Description

Almorexant (ACT 078573) hydrochloride is an orally active, potent, and competitive dual orexin receptor antagonist that reversibly blocks signaling by orexin-A and orexin-B peptides. Almorexant hydrochloride completely blocks the intracellular Ca2+ signaling pathway. Almorexant hydrochloride stimulates caspase-3 activity and induces apoptosis in AsPC-1 cells.

Molecular Weight 549.02
Formula C29H32ClF3N2O3
CAS No. 913358-93-7
Appearance Solid
Color White to off-white
SMILES CNC([C@@H](C1=CC=CC=C1)N2CCC3=CC(OC)=C(OC)C=C3[C@@H]2CCC4=CC=C(C(F)(F)F)C=C4)=O.Cl
Shipping Room temperature in continental US; may vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
In Vitro Almorexant (1 μM) promotes tyrosine phosphorylation of SHP2/OX1R complex.
Almorexant (1 μM) inhibits the cellular growth of AsPC-1 cells.
In Vivo Almorexant (1.8 μmol/kg, 100 μL; IP, daily) reduces the volume of tumors.
Almorexant (300 mg/kg, PO, once) can help rats to be fully capable of spatial and avoidance learning.
Almorexant (30-300 mg/kg) dose-dependently increases rapid eye movement (REM) and non-REM (NREM) sleep and decreases wakefulness apparently without inducing either cataplexy18 or deficits in next-day performance.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.